Biotech pharma

Harmonic Discovery

Website

We are a drug discovery company developing a new generation of therapeutics that embrace the complexity of disease. Currently available approaches for creating drugs work on the principle of finding one drug-one protein 'magic bullets'. However, diseases such as cancer and autoimmunity are often the result of several dysregulated proteins across ma

Founded 2021Origin source ↗Checked 2026-09-15

Overview

We are a drug discovery company developing a new generation of therapeutics that embrace the complexity of disease. Currently available approaches for creating drugs work on the principle of finding one drug-one protein 'magic bullets'. However, diseases such as cancer and autoimmunity are often the result of several dysregulated proteins across many distinct biological pathways.

We are building a computational-experimental platform to design therapeutics that can target several disease-causing proteins at once. By designing multi-specific drugs, we are able to create therapeutics that are more efficacious and safer than existing medicines.

Company description As recorded 2026-11-08
LinkedIn
Biotech pharmaAnalyticsBusinessesEnterpriseLicensing

Product & workflow

Our generative chemistry platform enables us to identify the correct modifications to molecules that tune out toxic off-targets

Source-reported As recorded 2026-09-16

Founders & team

Marcel Patek

Founder

I am a chemist with training in Medicinal, Organic, Computational, and Peptide chemistry. In my 25+ years in the field, I carried out drug discovery projects involving small molecules and peptides. I worked in environments of startup and global large pharma companies where I led teams and departments in all aspects of early drug discovery. I currently focus on merging experience-based knowledge of molecular optimization with ML/AI systems.

LinkedIn
Founder profile As recorded 2026-09-15
8team members reported
Source-reported As recorded 2026-09-15

Founded 2021 · Source

News & product activity

Sources & observations

Y Combinator

Profile depthverified profile
Website observationwebsite reachable
Last website check2026-11-11
Location · source statedNew York City, NY, USA; New York, NY, USA; Remote
Pricing evidenceNo pricing page confirmed
Maturity: Not assessed · 3 of 6 areas documented

Source-based assessment · automated evidence rules

The homepage contains prelaunch or closure language; availability needs review.

Maturity is an evidence-based assessment, not a success rating. It may understate the current stage where evidence is limited. Coverage records documented areas, not a complete or independently audited company history.

Stage definitions
independent websitesource corroborationreachable websitedescriptive evidenceclassified market and modelsourced peoplesourced founding year
startup.observe Directory coverage · Sources & method